- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03723018
Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors
Me-GC: A Randomized Controlled Trial of Meditation to Reduce Genetic Counselor Burnout and Genetic Counseling Student Stress
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will recruit 390-420 genetic counselors and 189-210 genetic counseling students. Participants will be randomized into one of three groups of roughly the same size: two meditation groups and an observational group. All three groups will fill out online surveys at several points in the study. The only thing the observational group will be asked to do is fill out these surveys. The meditation groups will be asked to meditate for 10 minutes a day for 8 weeks. Participants will be provided with an app or website that instructs them on how to meditate.
Outcome analyses will be done with an intention to treat approach. Outcomes will be assessed using linear regression with the outcome variable as the dependent variable and baseline outcome measure, baseline mindfulness, and treatment group as the independent variables. Secondary outcomes will be considered exploratory.
The study is funded by the Jane Engelberg Memorial Foundation
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Genetic counselors who provide direct clinical care
- Genetic counseling students
- Self-reported fluency in English
Exclusion Criteria:
- Living outside the US
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Meditation - Headspace
Participants in this arm will be asked to meditate daily for 10 minutes for 8 weeks.
Meditation instruction will be provided by the commercially available app/website Headspace (provided to participants for free).
Participants in this arm will have access to the other meditation arm once they finish the study.
|
10 minutes a day of meditation, done on your own time.
|
EXPERIMENTAL: Meditation - Respite
Participants in this arm will be asked to meditate daily for 10 minutes for 8 weeks.
Meditation instruction will be provided by Respite, a website created by the investigators for this study.
Participants in this arm will have access to the other meditation arm once they finish the study.
|
10 minutes a day of meditation, done on your own time.
|
NO_INTERVENTION: Observational
Participants in this arm will not receive any intervention.
Their only study activity will be taking online surveys.
They will have access to the two meditation arms once they finish the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Burnout (genetic counselors)
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
The primary outcome for genetic counselors is burnout, measured with the Professional Fulfillment Inventory
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Stress (genetic counseling students)
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
The primary outcome for genetic counseling students is stress, measured with the Perceived Stress Scale
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Other dimensions of professional well-being: Stress (genetic counselors only)
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Perceived Stress Scale
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Other dimensions of professional well-being: Professional fulfillment (genetic counselors only)
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Professional Fulfillment Index
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Other dimensions of professional well-being: Reactive distress
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Interpersonal Reactivity Index
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Other dimensions of professional well-being: Resilience
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Connor-Davidson Resilience Scale-10
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Cognitive empathy
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Interpersonal Reactivity Index
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Affective empathy
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Interpersonal Reactivity Index
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Working alliance
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Working Alliance Inventory
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Empathic understanding
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Barrett-Lennard Relationship Inventory
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Unconditional positive regard
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Barrett-Lennard Relationship Inventory
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Non-judging
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Five-Facet Mindfulness Questionnaire
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Determinants of counseling effectiveness: Non-reactivity
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Measured with the Five-Facet Mindfulness Questionnaire
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Retention in clinical roles
Time Frame: Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Retention in clinical roles, measured we will measure intention to reduce clinical load, using a custom item with a visual analogue scale.
|
Measured at the end of the intervention period, typically 8 weeks after starting the study.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Colleen Caleshu, Stanford University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB-48456
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genetic Counseling Profession
-
University of California, San FranciscoNational Cancer Institute (NCI); National Institutes of Health (NIH); University...CompletedGenetic CounselingUnited States
-
National Human Genome Research Institute (NHGRI)Completed
-
National Human Genome Research Institute (NHGRI)CompletedGenetic Counseling | AdoptionUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedHereditary Cancer | Genetic CounselingMexico
-
Erin RothwellNational Human Genome Research Institute (NHGRI)Not yet recruitingPregnancy | Shared Decision Making | Genetic Testing | Genetic Counseling | Prenatal DisorderUnited States
-
Hospital Clinic of BarcelonaCompletedGenetic Counseling | Prenatal DiagnosisSpain
-
National Human Genome Research Institute (NHGRI)CompletedGenetic Counseling | Moral Value Conflicts | Moral DistressUnited States
-
Central Hospital, Nancy, FranceCompletedGenetic Disease | CNV | Genetic Counseling | Array CGHFrance
-
Hospital Universitario La FeUnknownCancer | Psychological Distress | Hereditary Diseases | Genetic CounselingSpain
Clinical Trials on Meditation
-
University of California, San FranciscoCompleted
-
St. Louis UniversityCompletedStress | Premature Birth | Depression, Postpartum | Anxiety | Breast Feeding | Self Efficacy | Behavior, Maternal | Insufficient LactationUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Consuelo Lourdes Díaz RodríguezCompleted
-
Beth Israel Deaconess Medical CenterCompletedKnee Osteoarthritis | Osteo Arthritis Knee | Knee Injuries | Osteonecrosis | Opioid Use Disorder | Opioid Dependence | Arthropathy of Knee | Opioid Use | Meditation | Knee DiseaseUnited States
-
Georgetown UniversityCompleted
-
University of CopenhagenDanish Cancer SocietyUnknown
-
Centre Francois BaclesseRecruitingPatients With CancerFrance